Patent · US Active

Delivery of proteins using adeno-associated virus (AAV) vectors

US9527904B2 · kind B2 · utility

21Cited by
7References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 2014
Grant dateDec 27, 2016
Priority date—
Expiry dateSep 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compositions, systems and methods for delivery of proteins of interest using adeno-associated virus (AAV) vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.